- ANI Pharmaceuticals (NASDAQ:ANIP): Q3 Non-GAAP EPS of $0.97 beats by $0.09; GAAP EPS of $0.04 beats by $0.14.
- Revenue of $52.98M (+3.2% Y/Y) beats by $1.48M.
- Press Release
- https://seekingalpha.com/news/3631958-ani-pharmaceuticals-eps-beats-0_09-beats-on-revenue
Thursday, November 5, 2020
ANI Pharmaceuticals EPS beats by $0.09, beats on revenue
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.